Susceptibility Profile of Candida albicans Biofilms on Polyvinyl Chloride Endotracheal Tube to Antifungal Azoles

One of the most prevalent causative organisms in human fungal infections is Candida albicans. The extensive utility of medical devices such as endotracheal tube has resulted in the increased cases of fungal infections. The present study visualized Candida albicans biofilm on polyvinyl chloride endot...

Full description

Bibliographic Details
Main Authors:	Derick Erl P. Sumalapao, Frederico Martin D. Alegre, Pauline Bridgette D. Salazar, Nelson R. Villarante, Isidro C. Sia, Nina G. Gloriani
Format:	Article
Language:	English
Published:	Journal of Pure and Applied Microbiology 2020-06-01
Series:	Journal of Pure and Applied Microbiology
Subjects:	fluconazole fungal infections miconazole polymer-based material posaconazole standard disc diffusion method voriconazole
Online Access:	https://microbiologyjournal.org/susceptibility-profile-of-candida-albicans-biofilms-on-polyvinyl-chloride-endotracheal-tube-to-antifungal-azoles/

Similar Items

Conazoles
by: Jan Heeres, et al.
Published: (2010-06-01)

INK128 exhibits synergy with azoles against Exophiala spp. and Fusarium spp.
by: Lujuan Gao, et al.
Published: (2016-10-01)

In vitro and in vivo evaluation of antifungal combinations against azole-resistant Aspergillus fumigatus isolates
by: Sana Jemel, et al.
Published: (2023-01-01)

A clinico-mycological study of dermatophytoses and their in-vitro sensitivity to antifungal drugs
by: Manjunath Kadnur, et al.
Published: (2022-01-01)

Phaeohyphomycosis in Transplant Patients
by: Sanjay G. Revankar
Published: (2015-12-01)

Mechanisms of Azole Resistance and Trailing in <i>Candida tropicalis</i> Bloodstream Isolates
by: Pao-Yu Chen, et al.
Published: (2021-07-01)

Resurgence and Repurposing of Antifungal Azoles by Transition Metal Coordination for Drug Discovery
by: Youri Cortat, et al.
Published: (2023-09-01)

Phenotypic identification and antifungal susceptibility patterns of Candida species isolated from various clinical specimens in Suez Canal University Hospitals
by: Samaa Aboueldahab, et al.
Published: (2023-05-01)

MONITORING THE RESISTANCE OF CLINICAL STRAINS OF CANDIDA YEAST TO FLUCONAZOLE (A BRIEF LITERATURE REVIEW)
by: T. M. Zheltikova
Published: (2017-12-01)

Susceptibilidad a fluconazol y voriconazol por el método de difusión, de cepas de Candida, aisladas de hemocultivos en Maracaibo, Venezuela
by: Perozo-Mena Armindo, et al.
Published: (2011-12-01)

A Study on Subsite-specific Prevalence of Candidiasis in Head and Neck Cancer Patients and its Antifungal Susceptibility Pattern: A Cross-sectional Study
by: Neethu Babu, et al.
Published: (2023-10-01)

Sensibilidad a fluconazol y voriconazol de aislamientos de Candida spp., obtenidos de mucosa oral de pacientes con sida Sensitivity to Fluconazol and Voriconazol in Candida spp. isolates from the oral mucosa of HIV positive patients
by: Carolina Gutiérrez, et al.
Published: (2007-12-01)

Pharmacoeconomic evaluation of isavuconazole, posaconazole, and voriconazole for the treatment of invasive mold diseases in hematological patients: initial therapy prior to pathogen differential diagnosis in China
by: Guangxin Han, et al.
Published: (2023-12-01)

Olecranon bursitis caused by Scedosporium apiospermum in a patient treated with CAR-T cells
by: Willem J.J. Falkenburg, et al.
Published: (2022-12-01)

Treatment and Prevention of Histoplasmosis in Adults Living with HIV
by: David S. McKinsey
Published: (2021-05-01)

Trichosporon asahii Infection in an Extremely Preterm Infant in China
by: Wang N, et al.
Published: (2022-11-01)

Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy
by: Zahra Golestannejad, et al.
Published: (2022-01-01)

Effiectiveness of Etiotropic Therapy in Patients with Chronic Recurrent Oral Candidiasis: a Randomized Controlled Clinical Trial
by: Yu. A. Makedonova, et al.
Published: (2023-08-01)

Susceptibility to Fluconazole and Voriconazole in Candida Strains Isolated from Blood Culture by Disk Diffusion Method. Maracaibo, Venezuela
by: Armindo Perozo, et al.
Published: (2011-02-01)

Potential role of broad-spectrum azoles as therapy for Malasezzia bloodstream infection
by: Sunish Shah, et al.
Published: (2023-09-01)

Use of modeling and simulation to predict the influence of triazole antifungal agents on the pharmacokinetics of zanubrutinib and acalabrutinib
by: Lu Chen, et al.
Published: (2022-10-01)

Effects of Several Common Antifungal Drugs (Clotrimazole, Miconazole, Fluconazole) alone and in Combination with Amphotericin B on Candida Species Isolated from Chronic Candidal Vulvovaginitis
by: Efate alsadat shojaei, et al.
Published: (2014-11-01)

Insights into the Multi-Azole Resistance Profile in <i>Candida haemulonii</i> Species Complex
by: Laura Nunes Silva, et al.
Published: (2020-10-01)

Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China
by: Changcheng Shi, et al.
Published: (2022-05-01)

Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats
by: Yutao Lou, et al.
Published: (2023-08-01)

Phenotypic and molecular genetic profiles of fluconazole and voriconazole sensitive versus resistant candida spp
by: Madhavan, Priya
Published: (2014)

by: Daniela Silva Granzoto, et al.
Published: (2013-01-01)

A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan
by: Wen-Kai Chu, et al.
Published: (2023-02-01)

Characterization of the interferences of systemic azole antifungal drugs with adrenal steroid biosynthesis using H295R cells and enzyme activity assays
by: Marie-Christin Jäger, et al.
Published: (2023-01-01)

A fatal Acremonium falciforme peritonitis
by: Yasemin Ay Altintop1, et al.
Published: (2018-03-01)

Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China
by: Ting Zhao, et al.
Published: (2022-08-01)

Posaconazole as single or adjunctive antifungal in mucormycosis of the maxilla: systematic review and meta-analysis
by: Pardiwala Arwa, et al.
Published: (2023-01-01)

Voriconazole-Induced Hepatotoxicity in a Patient with Pulmonary Aspergillosis: A Case Report
by: Gu L, et al.
Published: (2023-08-01)

Evaluation of Antifungal Effect of Alcoholic Extract of Achillea Millefolium and Trachyspermum ammi Against Candida albicans Isolated from Denture Stomatitis
by: Nazli Ebrahim Netaj, et al.
Published: (2022-10-01)

Synergistic Activity of Ketoconazole and Miconazole with Prochloraz in Inducing Oxidative Stress, GSH Depletion, Mitochondrial Dysfunction, and Apoptosis in Mouse Sertoli TM4 Cells
by: Sabrina Petricca, et al.
Published: (2022-05-01)

Paradigm Shift: <i>Candida parapsilosis sensu stricto</i> as the Most Prevalent <i>Candida</i> Species Isolated from Bloodstream Infections with Increasing Azole-Non-Susceptibility Rates: Trends from 2015–2022 Survey
by: Iacopo Franconi, et al.
Published: (2023-10-01)

Antifungal effect of (R) and (S)-citronellal enantiomers and their predictive mechanism of action on Candida albicans from voriconazole-resistant onychomycoses
by: R. G. Gouveia, et al.
Published: (2023-05-01)

Susceptibility Patterns of <i>Candida</i> spp. Collected from Intensive Care Units: A Prospective Study in 2020–2022
by: Teresa Nascimento, et al.
Published: (2023-08-01)

Development of miconazole nitrate nanoparticles loaded in nanoemulgel to improve its antifungal activity
by: Dalal Y. Tayah, et al.
Published: (2023-04-01)

Clotrimazole drops or miconazole cream which is better for fungal ear infection
by: Omar Malik Bargas, et al.
Published: (2023-01-01)